KYMR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.82%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $40,176,324.03

Kymera Therapeutics Insider Trading History Chart

Kymera Therapeutics Share Price & Price History

^$47.02

▲ +2.04 (4.54%)

As of 11/25/2024 01:00 AM ET

Days: 30 | 90 | 365

Tim Sykes’ Urgent Trade Alert: “Make this move now”

From Timothy Sykes | Ad

WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…

Click here to see a unique election-year trade

Kymera Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/17/2024	Pamela Esposito	Director	Sell	13,500	$48.28	$651,780.00
8/26/2024	Jeffrey W. Albers	Director	Sell	5,000	$49.10	$245,500.00
7/16/2024	Jared Gollob	Insider	Sell	23,145	$45.81	$1,060,272.45	95,470
7/9/2024	Bruce Booth	Director	Sell	453,960	$38.21	$17,345,811.60	723,246
6/12/2024	Bruce Booth	Director	Sell	16,740	$35.45	$593,433.00	803,792
6/7/2024	Joanna Horobin	Director	Sell	8,500	$32.99	$280,415.00
3/15/2024	Bruce Booth	Director	Sell	71,764	$40.46	$2,903,571.44	806,697
3/13/2024	Bruce Booth	Director	Sell	139,255	$42.23	$5,880,738.65	828,830
3/13/2024	Venture Fund X L.P. Atlas	Major Shareholder	Sell	115,090	$42.23	$4,860,250.70	4,676,075
3/11/2024	Bruce Booth	Director	Sell	51,184	$42.85	$2,193,234.40	881,266
3/11/2024	Venture Fund X L.P. Atlas	Major Shareholder	Sell	42,302	$42.85	$1,812,640.70	4,925,812
3/4/2024	Bruce N. Jacobs	CFO	Sell	3,934	$41.86	$164,677.24	142,351
2/21/2024	Jeffrey W. Albers	Director	Sell	4,385	$39.05	$171,234.25
2/9/2024	Jared Gollob	Insider	Sell	46,137	$35.50	$1,637,863.50	74,709
1/23/2024	Jeffrey W. Albers	Director	Sell	10,000	$30.05	$300,500.00
1/4/2024	Ellen Chiniara	Insider	Sell	3,295	$22.58	$74,401.10	34,205
11/2/2023	Bvf Partners L P/Il	Director	Buy	216,406	$11.64	$2,518,965.84	2,552,306
3/2/2023	Bruce N. Jacobs	CFO	Sell	1,370	$31.00	$42,470.00	104,568
1/11/2023	Bvf Partners L P/Il	Director	Buy	22,110	$29.89	$660,867.90	2,491,703
1/11/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	21,683	$29.96	$649,622.68	5,045,242
12/14/2022	Bruce Booth	Director	Sell	378,966	$31.37	$11,888,163.42	918,528
12/14/2022	Venture Fund X L.P. Atlas	Major Shareholder	Sell	296,077	$31.37	$9,287,935.49	5,069,486
11/2/2022	Bruce Booth	Director	Sell	123,619	$30.02	$3,711,042.38	1,022,502
11/2/2022	Venture Fund X L.P. Atlas	Major Shareholder	Sell	96,581	$30.02	$2,899,361.62	5,440,875
10/31/2022	Bruce Booth	Director	Sell	120,622	$30.23	$3,646,403.06	1,066,388
10/31/2022	Venture Fund X L.P. Atlas	Major Shareholder	Sell	94,239	$30.23	$2,848,844.97	5,597,638
10/28/2022	Bruce Booth	Director	Sell	91,050	$30.00	$2,731,500.00	1,092,771
10/28/2022	Venture Fund X L.P. Atlas	Major Shareholder	Sell	71,135	$30.00	$2,134,050.00	5,691,877
8/22/2022	Bvf Partners L P/Il	Director	Buy	545,525	$26.00	$14,183,650.00	2,480,742
5/26/2022	Bvf Partners L P/Il	Director	Buy	224,057	$14.21	$3,183,849.97	2,159,903
5/20/2022	Bvf Partners L P/Il	Director	Buy	10,100	$14.00	$141,400.00	2,036,860
5/5/2022	Bvf Partners L P/Il	Director	Buy	150,000	$19.60	$2,940,000.00	1,975,767
1/31/2022	Bvf Partners L P/Il	Director	Buy	34,408	$40.70	$1,400,405.60
1/27/2022	Bvf Partners L P/Il	Director	Buy	95,901	$38.33	$3,675,885.33
1/24/2022	Bvf Partners L P/Il	Director	Buy	272,767	$37.76	$10,299,681.92
1/12/2022	Bruce N. Jacobs	CFO	Sell	15,000	$51.85	$777,750.00
1/12/2022	Nello Mainolfi	CEO	Sell	8,612	$52.08	$448,512.96
1/10/2022	Nello Mainolfi	CEO	Sell	22,465	$53.26	$1,196,485.90
12/3/2021	Bruce N. Jacobs	CFO	Sell	10,000	$53.56	$535,600.00

Ever heard of this 8-day bitcoin profit window?

From ProsperityPub | Ad

Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.

It’s coming up quick.

SEC Filings (Institutional Ownership Changes) for Kymera Therapeutics (NASDAQ:KYMR)

Institutional Buying and Selling by Quarter

Kymera Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/18/2024	Teachers Retirement System of The State of Kentucky	21,305	$1.01M	0.0%	-17.8%	0.033%
11/16/2024	Geode Capital Management LLC	1,053,224	$49.86M	0.0%	-0.1%	1.626%
11/15/2024	XTX Topco Ltd	5,987	$0.28M	0.0%	-11.3%	0.009%
11/15/2024	Wellington Management Group LLP	4,618,359	$218.59M	0.0%	+7.2%	7.131%
11/15/2024	Two Sigma Advisers LP	336,300	$15.92M	0.0%	-8.4%	0.519%
11/15/2024	State Street Corp	1,728,144	$81.79M	0.0%	-9.6%	2.668%
11/15/2024	Quarry LP	2,000	$95K	0.0%	N/A	0.003%
11/15/2024	Redmile Group LLC	1,393,256	$65.94M	3.9%	-11.8%	2.151%
11/15/2024	Janus Henderson Group PLC	15,108	$0.71M	0.0%	-19.7%	0.023%
11/15/2024	HighTower Advisors LLC	10,449	$0.49M	0.0%	N/A	0.016%
11/15/2024	HighVista Strategies LLC	12,743	$0.60M	0.2%	N/A	0.020%
11/15/2024	Cinctive Capital Management LP	56,801	$2.69M	0.1%	N/A	0.088%
11/15/2024	Bamco Inc. NY	25,000	$1.18M	0.0%	N/A	0.039%
11/15/2024	Erste Asset Management GmbH	27,000	$1.32M	0.0%	N/A	0.042%
11/14/2024	Fred Alger Management LLC	18,141	$0.86M	0.0%	N/A	0.028%
11/14/2024	Eventide Asset Management LLC	507,902	$24.04M	0.4%	+9.9%	0.784%
11/14/2024	Verition Fund Management LLC	5,135	$0.24M	0.0%	-35.5%	0.008%
11/14/2024	Walleye Capital LLC	9,976	$0.47M	0.0%	N/A	0.015%
11/14/2024	PEAK6 Investments LLC	15,000	$0.71M	0.0%	+15.4%	0.023%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	428,529	$20.28M	0.0%	-1.2%	0.662%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	11,289	$0.53M	0.0%	+8.8%	0.017%
11/13/2024	FMR LLC	5,109,141	$241.82M	0.0%	+5.8%	7.889%
11/13/2024	The Manufacturers Life Insurance Company	128,267	$6.07M	0.0%	-1.4%	0.198%
11/12/2024	Algert Global LLC	30,256	$1.43M	0.0%	-7.5%	0.047%
11/12/2024	Charles Schwab Investment Management Inc.	366,841	$17.36M	0.0%	-2.2%	0.566%
11/12/2024	Massachusetts Financial Services Co. MA	453,377	$21.46M	0.0%	+11.7%	0.700%
11/9/2024	Intech Investment Management LLC	13,727	$0.65M	0.0%	N/A	0.021%
11/8/2024	Jennison Associates LLC	797,681	$37.75M	0.0%	+85.8%	1.232%
11/7/2024	Quest Partners LLC	3,418	$0.16M	0.0%	-34.4%	0.005%
11/7/2024	Thrivent Financial for Lutherans	6,617	$0.31M	0.0%	N/A	0.010%
11/6/2024	Natixis Advisors LLC	14,378	$0.68M	0.0%	N/A	0.022%
11/5/2024	Aigen Investment Management LP	5,794	$0.27M	0.1%	-25.6%	0.009%
11/5/2024	GSA Capital Partners LLP	21,482	$1.02M	0.1%	-22.0%	0.033%
10/31/2024	Keudell Morrison Wealth Management	4,830	$0.23M	0.1%	-32.0%	0.008%
10/29/2024	Harbor Capital Advisors Inc.	40,303	$1.91M	0.1%	+30.0%	0.066%
10/28/2024	US Bancorp DE	1,465	$69K	0.0%	-30.8%	0.002%
10/25/2024	Integrated Advisors Network LLC	6,218	$0.29M	0.0%	N/A	0.010%
10/25/2024	China Universal Asset Management Co. Ltd.	12,422	$0.59M	0.1%	+72.3%	0.020%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	2,336	$0.11M	0.0%	+27.5%	0.004%
10/23/2024	Values First Advisors Inc.	1,296	$61K	0.0%	N/A	0.002%
10/10/2024	Exchange Traded Concepts LLC	3,454	$0.16M	0.0%	-37.2%	0.006%
10/5/2024	Handelsbanken Fonder AB	17,300	$0.82M	0.0%	+12.3%	0.028%
10/3/2024	SG Americas Securities LLC	14,719	$0.70M	0.0%	+35.2%	0.024%
9/20/2024	Healthcare of Ontario Pension Plan Trust Fund	64,000	$1.91M	0.0%	N/A	0.104%
8/16/2024	Algert Global LLC	32,706	$0.98M	0.0%	+16.5%	0.053%
8/16/2024	Driehaus Capital Management LLC	223,413	$6.67M	0.1%	N/A	0.364%
8/15/2024	Susquehanna Portfolio Strategies LLC	14,476	$0.43M	0.0%	-20.4%	0.024%
8/15/2024	Susquehanna Fundamental Investments LLC	76,818	$2.29M	0.1%	+7.4%	0.125%
8/15/2024	The Manufacturers Life Insurance Company	130,077	$3.88M	0.0%	+13.3%	0.212%
8/14/2024	Squarepoint Ops LLC	108,563	$3.24M	0.0%	+27.3%	0.177%
8/14/2024	Marshall Wace LLP	376,562	$11.24M	0.0%	-34.3%	0.614%
8/14/2024	ProShare Advisors LLC	9,250	$0.28M	0.0%	-20.3%	0.015%
8/14/2024	Profund Advisors LLC	17,011	$0.51M	0.0%	-48.2%	0.028%
8/13/2024	Public Employees Retirement Association of Colorado	4,672	$0.14M	0.0%	N/A	0.008%
8/12/2024	XTX Topco Ltd	6,748	$0.20M	0.0%	N/A	0.011%
8/12/2024	Hsbc Holdings PLC	18,182	$0.55M	0.0%	+81.0%	0.030%
8/12/2024	E Fund Management Co. Ltd.	48,946	$1.46M	0.1%	+391.2%	0.080%
8/9/2024	Renaissance Technologies LLC	143,093	$4.27M	0.0%	N/A	0.233%
8/9/2024	Dimensional Fund Advisors LP	402,385	$12.01M	0.0%	+15.2%	0.656%
8/9/2024	Massachusetts Financial Services Co. MA	405,870	$12.12M	0.0%	+2.7%	0.661%
8/9/2024	Atlas Venture Life Science Advisors LLC	5,350,422	$159.71M	16.8%	-0.5%	8.720%
8/8/2024	American Century Companies Inc.	10,847	$0.32M	0.0%	-77.2%	0.018%
8/6/2024	Quest Partners LLC	5,212	$0.16M	0.0%	+1,402.0%	0.008%
8/6/2024	Candriam S.C.A.	238,165	$7.11M	0.0%	-27.5%	0.388%
8/5/2024	Arizona State Retirement System	12,830	$0.38M	0.0%	+15.6%	0.021%
8/1/2024	Rhumbline Advisers	64,535	$1.93M	0.0%	+12.4%	0.105%
7/29/2024	Principal Financial Group Inc.	8,190	$0.24M	0.0%	-32.3%	0.013%
7/26/2024	Bank of New York Mellon Corp	156,211	$4.66M	0.0%	+19.3%	0.255%
7/17/2024	Keudell Morrison Wealth Management	7,105	$0.21M	0.1%	+7.2%	0.012%
7/12/2024	SG Americas Securities LLC	10,887	$0.33M	0.0%	+175.4%	0.018%
7/9/2024	Harbor Capital Advisors Inc.	31,011	$0.93M	0.1%	-25.0%	0.051%
6/4/2024	DekaBank Deutsche Girozentrale	23,562	$0.95M	0.0%	+7.1%	0.038%
5/20/2024	Virtu Financial LLC	5,147	$0.21M	0.0%	N/A	0.008%
5/17/2024	Artal Group S.A.	3,027,135	$121.69M	3.1%	+19.6%	4.933%
5/17/2024	Comerica Bank	3,324	$0.13M	0.0%	+13.7%	0.005%
5/16/2024	California State Teachers Retirement System	40,423	$1.63M	0.0%	+5.5%	0.066%
5/16/2024	Bayesian Capital Management LP	14,150	$0.57M	0.1%	N/A	0.023%
5/16/2024	Redmile Group LLC	1,734,089	$69.71M	2.6%	-4.9%	2.826%
5/15/2024	Price T Rowe Associates Inc. MD	6,332,012	$254.55M	0.0%	+18.7%	10.319%
5/15/2024	Avoro Capital Advisors LLC	3,888,888	$156.33M	1.8%	+3.0%	6.338%
5/14/2024	Nan Fung Group Holdings Ltd	10,875	$0.44M	0.4%	N/A	0.018%
5/14/2024	Natixis	1,979	$80K	0.0%	-50.2%	0.003%
5/14/2024	American International Group Inc.	20,095	$0.81M	0.0%	+6.4%	0.033%
5/13/2024	Seven Eight Capital LP	15,963	$0.64M	0.1%	-28.8%	0.026%
5/13/2024	Ameritas Investment Partners Inc.	4,070	$0.16M	0.0%	+7.8%	0.007%
5/10/2024	Vanguard Group Inc.	4,767,050	$191.64M	0.0%	+19.2%	7.769%
5/9/2024	State Board of Administration of Florida Retirement System	12,645	$0.51M	0.0%	+15.7%	0.021%
5/8/2024	ProShare Advisors LLC	11,609	$0.47M	0.0%	+18.0%	0.019%
5/8/2024	Russell Investments Group Ltd.	51,757	$2.08M	0.0%	+5.4%	0.084%
5/7/2024	Keudell Morrison Wealth Management	6,625	$0.27M	0.1%	N/A	0.011%
5/7/2024	Susquehanna Fundamental Investments LLC	71,493	$2.87M	0.1%	N/A	0.117%
5/7/2024	Swiss National Bank	79,700	$3.20M	0.0%	+12.3%	0.130%
5/7/2024	Nvwm LLC	7,304	$0.29M	0.1%	N/A	0.012%
5/7/2024	SG Americas Securities LLC	3,953	$0.16M	0.0%	-78.7%	0.006%
5/6/2024	Atlas Venture Life Science Advisors LLC	5,377,362	$216.17M	19.9%	-8.2%	8.764%
5/3/2024	GSA Capital Partners LLP	11,645	$0.47M	0.0%	-48.4%	0.019%
5/2/2024	Jennison Associates LLC	425,920	$17.12M	0.0%	N/A	0.694%
5/2/2024	FORA Capital LLC	20,343	$0.82M	0.1%	N/A	0.033%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	24,471	$0.98M	0.0%	+6.7%	0.040%
4/29/2024	Principal Financial Group Inc.	12,098	$0.49M	0.0%	+4.7%	0.020%

Data available starting January 2016

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company develops STAT6, a Type 2 inflammation in allergic diseases; and TYK2, a treatment for inflammatory bowel disease, psoriasis, psoriatic arthritis, and lupus. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $47.02

$45.38

$48.29

50 Day Range

MA: $46.94

$41.96

$52.40

52 Week Range

Now: $47.02

$18.89

$53.27

Volume

545,608 shs

Average Volume

586,517 shs

Market Capitalization

$3.05 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.21

Who are the company insiders with the largest holdings of Kymera Therapeutics?: Kymera Therapeutics' top insider shareholders include:
Venture Fund X LP Atlas (Major Shareholder)
Bvf Partners L P/Il (Director)
Bruce Booth (Director)
Bruce N Jacobs (CFO)
Jared Gollob (Insider)
Ellen Chiniara (Insider)
Jeffrey W Albers (Director)
Joanna Horobin (Director)
Pamela Esposito (Director)
Learn More about top insider investors at Kymera Therapeutics.
Who are the major institutional investors of Kymera Therapeutics?: Kymera Therapeutics' top institutional shareholders include:
FMR LLC — 7.89%
Wellington Management Group LLP — 7.13%
State Street Corp — 2.67%
Redmile Group LLC — 2.15%
Geode Capital Management LLC — 1.63%
Jennison Associates LLC — 1.23%
Learn More about top institutional investors of Kymera Therapeutics stock.
Which major investors are selling Kymera Therapeutics stock?: During the previous quarter, KYMR stock was sold by these institutional investors:
Redmile Group LLC
State Street Corp
Two Sigma Advisers LP
Charles Schwab Investment Management Inc.
GSA Capital Partners LLP
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Teachers Retirement System of The State of Kentucky
Janus Henderson Group PLC
Within the previous year, company insiders that have sold Kymera Therapeutics company stock include:
Venture Fund X LP Atlas (Major Shareholder)
Bvf Partners L P/Il (Director)
Bruce Booth (Director)
Bruce N Jacobs (CFO)
Jared Gollob (Insider)
Ellen Chiniara (Insider)
Jeffrey W Albers (Director)
Joanna Horobin (Director)
Learn More investors selling Kymera Therapeutics stock.
Which major investors are buying Kymera Therapeutics stock?: In the previous quarter, KYMR stock was purchased by institutional investors including:
Jennison Associates LLC
Wellington Management Group LLP
FMR LLC
Cinctive Capital Management LP
Massachusetts Financial Services Co. MA
Eventide Asset Management LLC
Barclays PLC
Erste Asset Management GmbH